Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma.

Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma. J Neurooncol. 2024 Feb; 166(3):569-574.

View in: PubMed